Designing RNase H1 "Gapmer" Antisense Oligonucleotides

This content is brought to you by Integrated DNA Technologies, a Danaher Operating Company.

Advances in antisense oligonucleotide (ASO) design have expanded the possibilities for precise gene regulation, but achieving potent, selective, and safe RNA targeting requires careful optimization. RNase H1 gapmer ASOs rely on DNA–RNA hybrid formation to trigger catalytic degradation of target transcripts, making sequence selection and chemical modification critical. Strategic use of phosphorothioate backbones, 2’-ribose modifications, and nucleobase substitutions enables control over stability, binding affinity, and cellular uptake, while balancing risks such as off-target activity and toxicity. Effective designs also consider factors like GC content, secondary structure, and target accessibility, alongside delivery strategies ranging from gymnotic uptake to ligand conjugation for tissue-specific targeting.

Gain insight into a practical framework that improves ASO performance and translational success.